Arena Pharmaceuticals, (ARNA) Posts Wider than Expected Q4 Loss of 16c/Share
Tweet Send to a FriendGet Alerts ARNA Hot Sheet
Price: $8.30 +2.98%
Financial Fact:
Collaborative agreements: 1.61M
Today's EPS Names:
ANF, DXLG, FL, More
Financial Fact:
Collaborative agreements: 1.61M
Today's EPS Names:
ANF, DXLG, FL, More
Trade ARNA Now!
Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) reported Q4 EPS of ($0.16), $0.01 worse than the analyst estimate of ($0.15). Revenue for the quarter came in at $2.08 million versus the consensus estimate of $3.49 million.
For earnings history and earnings-related data on Arena Pharmaceuticals, Inc. (ARNA) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Arena Pharmaceuticals, Inc. (ARNA) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Abercrombie & Fitch Co. (ANF) Misses Q1 EPS by 4c; Guides FY Below Views
- salesforce.com, Inc. (CRM) Reports In-Line Q1 EPS; Issues In-Line Q2, FY14 Outlook
- Destination Xl Grp (DXLG) Tops Q1 EPS by 1c; Comps Up 17.7%
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
